Is a pharmacogenomic panel useful to estimate the risk of oxaliplatinrelated neurotoxicity in colorectal cancer patients
Bioportfolio,
Related Biotechnology, Pharmaceutical and Healthcare News Original Article: Is a pharmacogenomic panel useful to estimate the…